Literature DB >> 34618227

Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.

A Debernardi1, W Jarassier2, C Soret1,2, C Mougin1,2, S Alizon3, I G Bravo3,4, D Guenat1,2, J L Prétet1,2, Q Lepiller5,6,7.   

Abstract

Simple and standardized approaches for genome analysis of human papillomavirus (HPV) by next-generation sequencing are needed. The aim of the study was to develop a protocol for direct deep sequencing of high-risk (hr) HPV strains, based on the widely used commercial Hybrid Capture 2 (QIAGEN) test, without any additional probe design. This protocol was applied to 15 HPV-positive and two HPV-negative cervical samples or cell lines and validated at the genotype level by comparing the sequencing results to those obtained using a commercial genotyping kit. The performance of our protocol, presented in this proof-of-principle study, supports its use for accurate characterization of genetic variants of hrHPV.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34618227     DOI: 10.1007/s00705-021-05259-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

Review 1.  Human papillomavirus genome variants.

Authors:  Robert D Burk; Ariana Harari; Zigui Chen
Journal:  Virology       Date:  2013-08-31       Impact factor: 3.616

2.  Real-time duplex PCR for simultaneous HPV 16 and HPV 18 DNA quantitation.

Authors:  Elise Jacquin; Maëlle Saunier; Frédéric Mauny; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Virol Methods       Date:  2013-07-24       Impact factor: 2.014

3.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

4.  Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms.

Authors:  I Zehbe; G Voglino; H Delius; E Wilander; M Tommasino
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

5.  C33-A cells transfected with E6*I or E6*II the short forms of HPV-16 E6, displayed opposite effects on cisplatin-induced apoptosis.

Authors:  Carolina E Vaisman; Oscar Del Moral-Hernandez; Samadhi Moreno-Campuzano; Elena Aréchaga-Ocampo; Raul Bonilla-Moreno; Israel Garcia-Aguiar; Leticia Cedillo-Barron; Jaime Berumen; Porfirio Nava; Nicolas Villegas-Sepúlveda
Journal:  Virus Res       Date:  2018-02-13       Impact factor: 3.303

6.  International standardization and classification of human papillomavirus types.

Authors:  Davit Bzhalava; Carina Eklund; Joakim Dillner
Journal:  Virology       Date:  2015-01-09       Impact factor: 3.616

7.  Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older.

Authors:  Chris J L M Meijer; Johannes Berkhof; Philip E Castle; Albertus T Hesselink; Eduardo L Franco; Guglielmo Ronco; Marc Arbyn; F Xavier Bosch; Jack Cuzick; Joakim Dillner; Daniëlle A M Heideman; Peter J F Snijders
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

8.  Worldwide burden of cancer attributable to HPV by site, country and HPV type.

Authors:  Catherine de Martel; Martyn Plummer; Jerome Vignat; Silvia Franceschi
Journal:  Int J Cancer       Date:  2017-06-08       Impact factor: 7.396

9.  The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.

Authors:  Lisa Mirabello; Megan A Clarke; Chase W Nelson; Michael Dean; Nicolas Wentzensen; Meredith Yeager; Michael Cullen; Joseph F Boland; Mark Schiffman; Robert D Burk
Journal:  Viruses       Date:  2018-02-13       Impact factor: 5.048

10.  Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism.

Authors:  Philippe Paget-Bailly; Koceila Meznad; Diane Bruyère; Jérôme Perrard; Michael Herfs; Alain C Jung; Christiane Mougin; Jean-Luc Prétet; Aurélie Baguet
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.